Stay updated on Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new version entry v3.3.2 was added and the previous v3.3.1 entry was removed. This update relates to versioning metadata in the record history rather than substantive study content.
    Difference
    0.1%
    Check dated 2025-12-01T16:26:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page header now shows Revision: v3.3.1, replacing v3.2.0. No other study data or content on the history page appears changed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:43:22.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the banner about a lapse in government funding and NIH operating status from the page header; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T06:19:03.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Old and New screenshots show the same Record History layout and content; no additions or deletions in the page sections are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:53:54.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    11%
    Check dated 2025-10-05T09:09:27.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:06:13.000Z thumbnail image

Stay in the know with updates to Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.